drugset / Trial / NCT05636618
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors
Timeline
- Start
- 2023-09-27
- Primary completion
- 2029-11-26
- Completion
- 2029-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [203Pb]VMT-α-NET | Diagnostic / imaging agent | — | Intravenous |
| Subject | [212Pb]VMT-α-NET | Peptide | — | Intravenous |